These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6696371)

  • 1. Ticarcillin and assay of tobramycin.
    Dalmady-Israel C; Green PJ; Sloskey GE; Vlasses PH
    Ann Intern Med; 1984 Mar; 100(3):460-1. PubMed ID: 6696371
    [No Abstract]   [Full Text] [Related]  

  • 2. Mall order tobramycin serum levels: low values caused by ticarcillin.
    Polk RE; Kline BJ
    Am J Hosp Pharm; 1980 Jul; 37(7):920, 922. PubMed ID: 7395883
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuation of experimental tobramycin nephrotoxicity by ticarcillin.
    English J; Gilbert DN; Kohlhepp S; Kohnen PW; Mayor G; Houghton DC; Bennett WM
    Antimicrob Agents Chemother; 1985 Jun; 27(6):897-902. PubMed ID: 4026263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and biological activities of tobramycin-ticarcillin adducts.
    Huh K; Wilton JH; Nix DE; Schentag JJ
    J Pharm Sci; 1994 Jun; 83(6):763-7. PubMed ID: 9120803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease.
    Matzke GR; Luckham DR; Collins AJ; Halstenson CE
    Pharmacotherapy; 1984; 4(3):158-60. PubMed ID: 6739313
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
    Falkowski AJ; Creger RJ
    Antimicrob Agents Chemother; 1984 Nov; 26(5):643-6. PubMed ID: 6393865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inactivation of tobramycin by ticarcillin. A case report.
    Chow MS; Quintiliani R; Nightingale CH
    JAMA; 1982 Feb; 247(5):658-9. PubMed ID: 6798229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
    Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
    Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB
    J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U
    Chemotherapy; 1977; 23(5):314-23. PubMed ID: 409590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inactivation of gentamicin by carbenicillin and ticarcillin.
    Kradjan WA; Burger R
    Arch Intern Med; 1980 Dec; 140(12):1668-70. PubMed ID: 7458498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.
    Just HM; Becker C; Gieringer J; Wenz A; Bassler M; Daschner F
    Drugs; 1985; 29 Suppl 5():74-7. PubMed ID: 4029031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporin-ticarcillin interaction in a renal transplant patient].
    Lambert C; Pointet P; Ducret F
    Presse Med; 1989 Feb; 18(5):230. PubMed ID: 2522215
    [No Abstract]   [Full Text] [Related]  

  • 15. Gentamicin and ticarcillin in subjects with end-stage renal disease. Comparison of two assay methods and evaluation of inactivation rate.
    Russo ME; Atkin-Thor E
    Clin Nephrol; 1981 Apr; 15(4):175-80. PubMed ID: 7237864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chequerboard titrations: the influence of the composition of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index.
    Horrevorts AM; de Ridder CM; Poot MC; de Jonge MJ; Degener JE; Dzoljic-Danilovic G; Michel MF; Kerrebijn KF
    J Antimicrob Chemother; 1987 Jan; 19(1):119-25. PubMed ID: 3104274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.
    Roberts GW; Nation RL; Jarvinen AO; Martin AJ
    Br J Clin Pharmacol; 1993 Oct; 36(4):372-5. PubMed ID: 12959319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of ticarcillin in patients with abnormal renal function.
    Parry MF; Neu HC
    J Infect Dis; 1976 Jan; 133(1):46-9. PubMed ID: 1107435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antibacterial activity of azlocillin and ticarcillin in vitro and in irradiated neutropenic mice.
    van der Voet GB; Mattie H; van Furth R
    J Antimicrob Chemother; 1985 Nov; 16(5):605-13. PubMed ID: 3935638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.